Polymedco

You can prevent colorectal cancer by getting regular screenings for colorectal cancer, eating lots of vegetables, fruits, and whole grains.

Epi proColon is a non-invasive test for colorectal cancer screening which detects the DNA that is associated with colorectal cancer.

FOBT/FIT has been very beneficial in saving lives by reaching larger populations with at-risk stages of colorectal cancer.

Polymedco CDP, LLC offers high quality colon cancer screening products, including OC-Auto® FIT, OC-Light® S FIT and Epi proColon.

A fecal immunochemical test (FIT) can detect small amounts of blood in the stool which may not be visible to the naked eye.

Colorectal cancer/colon cancer is hereditary. A family history of colorectal cancer increases a person's risk of developing colorectal cancer.

People who are at an average risk for colorectal cancer (anyone above 45 years) as well as people with high risk for developing CRC should be screened.

A Cologuard test may not be appropriate for everyone. This test is not a replacement for diagnostic or surveillance colonoscopy in high-risk individuals.

Fecal immunochemical tests (FIT) detect small amounts of blood in stool which can be an early sign of colorectal cancer.

Systematic screening is done by using a combined screening model of fecal immunochemical test and colonoscopy through primary-care physician referral.

A colonoscope is used to perform a colonoscopy. This instrument is used to view the inner lining of the large intestine, that is, the rectum and colon.

Colorectal cancer is the third leading cause of cancer-related deaths in the United States. The lifetime risk of developing colorectal cancer is about 1 in 21 for men and 1 in 23 for women.